Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| IMNN | IMUNON INC | $14.47M | 2,192,353 | 11.31% | 88.69% | Net Buying | Net Buying | ||
| ACXP | ACURX PHARMACEUTICALS INC | $7.70M | 1,584,775 | 30.60% | 69.40% | Net Buying | |||
| AEMD | AETHLON MEDICAL INC | $3.04M | 2,598,711 | 0.04% | 99.96% | Net Buying | Net Selling | ||
| FBLG | FIBROBIOLOGICS INC | $24.63M | 41,889,142 | 8.26% | 14.47% | Net Buying | Net Buying | ||
| CODX | CO-DIAGNOSTICS INC | $10.21M | 38,523,582 | 11.96% | 25.74% | Net Selling | Net Selling | ||
| PSTV | PLUS THERAPEUTICS INC | $17.73M | 32,717,054 | 0.32% | 71.44% | Net Buying | |||
| MRSN | MERSANA THERAPEUTICS INC | $37.03M | 4,990,692 | 10.68% | 89.32% | Net Selling | |||
| REE | REE AUTOMOTIVE LTD | $15.34M | 22,259,447 | 21.36% | 45.27% | ||||
| UNCY | UNICYCIVE THERAPEUTICS INC | $55.85M | 12,062,928 | 4.77% | 95.23% | ||||
| FGEN | FIBROGEN INC | $38.34M | 4,043,899 | 5.09% | 94.91% | Net Buying | Net Buying | ||
| GRI | GRI BIO INC | $3.08M | 2,141,473 | 0.01% | 99.99% | ||||
| XFOR | X4 PHARMACEUTICALS INC | $18.18M | 5,788,686 | 8.98% | 91.02% | Net Selling | Net Buying | ||
| CBUS | CIBUS INC | $50.55M | 34,384,554 | 6.50% | 93.50% | Net Buying | Net Buying | ||
| LFWD | LIFEWARD LTD | $6.74M | 11,007,592 | 0.99% | 99.01% | Net Selling | Net Selling | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $32.05M | 57,542,105 | 4.48% | 38.43% | Net Selling | |||
| OKUR | ONKURE THERAPEUTICS INC | $36.12M | 13,529,961 | 12.12% | 87.88% | Net Buying | Net Selling | ||
| MDCX | MEDICUS PHARMA LTD | $35.28M | 17,816,266 | 10.73% | 54.53% | Net Selling | Net Selling | ||
| MTVA | METAVIA INC | $15.49M | 24,197,809 | 0.58% | 99.42% | Net Buying | Net Buying | ||
| GOVX | GEOVAX LABS INC | $19.05M | 25,359,593 | 0.11% | 99.89% | Net Buying | Net Buying | ||
| EKSO | EKSO BIONICS HOLDINGS INC | $8.33M | 2,611,788 | 0.26% | 99.74% | ||||
| IGC | IGC PHARMA INC | $30.20M | 83,891,586 | 2.81% | 24.17% | Net Buying | |||
| NRXP | NRX PHARMACEUTICALS INC | $46.16M | 17,289,192 | 2.16% | 97.84% | Net Buying | |||
| CLSD | CLEARSIDE BIOMEDICAL INC | $34.89M | 77,708,536 | 10.31% | 35.27% | Net Buying | |||
| ACRV | ACRIVON THERAPEUTICS INC | $43.72M | 31,455,645 | 13.76% | 47.48% | Net Selling | Net Selling | ||
| SGMO | SANGAMO THERAPEUTICS INC | $162.92M | 301,709,485 | 10.34% | 10.66% | Net Selling | Net Selling | ||
| CRIS | CURIS INC | $21.00M | 12,498,853 | 2.61% | 97.39% | ||||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $9.46M | 1,261,290 | 0.16% | 99.84% | Net Selling | |||
| CABA | CABALETTA BIO INC | $83.73M | 50,743,101 | 31.90% | 8.32% | ||||
| CMMB | CHEMOMAB THERAPEUTICS LTD | $16.92M | 377,256,460 | 0.18% | 4.49% | ||||
| FEMY | FEMASYS INC | $20.21M | 27,239,885 | 7.61% | 8.37% | Net Buying | Net Buying | ||
| IFRX | INFLARX NV | $56.03M | 67,747,130 | 0.65% | 0.00% | ||||
| BOLT | BOLT BIOTHERAPEUTICS INC | $10.43M | 1,916,985 | 1.62% | 98.38% | Net Buying | |||
| IMUX | IMMUNIC INC | $87.86M | 95,817,536 | 15.46% | 16.57% | Net Buying | Net Buying | ||
| OSTX | OS THERAPIES INC | $60.41M | 28,097,697 | 1.77% | 23.50% | Net Selling | |||
| IVVD | INVIVYD INC | $95.85M | 119,961,445 | 23.88% | 76.12% | Net Selling | |||
| VIR | VIR BIOTECHNOLOGY INC | $616.79M | 138,916,426 | 37.18% | 39.28% | Net Selling | Net Selling | ||
| ACET | ADICET BIO INC | $53.76M | 82,709,625 | 15.65% | 19.44% | Net Selling | |||
| MYO | MYOMO INC | $37.05M | 37,801,070 | 31.89% | 10.86% | Net Selling | Net Selling | ||
| MBRX | MOLECULIN BIOTECH INC | $19.63M | 30,286,168 | 1.38% | 20.90% | Net Buying | Net Buying | ||
| JSPR | JASPER THERAPEUTICS INC | $49.25M | 16,253,332 | 6.03% | 93.97% | Net Buying | |||
| MRKR | MARKER THERAPEUTICS INC | $14.14M | 11,314,835 | 1.05% | 98.95% | Net Buying | |||
| CLNN | CLENE INC | $32.34M | 8,982,747 | 0.99% | 99.01% | Net Buying | Net Selling | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $59.23M | 44,873,646 | 6.47% | 66.79% | Net Buying | |||
| ATOS | ATOSSA THERAPEUTICS INC | $100.75M | 129,171,424 | 9.80% | 11.04% | Net Buying | Net Buying | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $237.41M | 221,881,029 | 42.76% | 35.22% | Net Selling | Net Selling | ||
| PASG | PASSAGE BIO INC | $24.13M | 3,178,710 | 18.42% | 81.58% | Net Selling | Net Selling | ||
| BTAI | BIOXCEL THERAPEUTICS INC | $69.14M | 14,556,743 | 0.23% | 99.77% | Net Selling | |||
| CNTX | CONTEXT THERAPEUTICS INC | $66.02M | 89,704,194 | 21.30% | 1.46% | Net Buying | Net Buying | ||
| CING | CINGULATE INC | $17.53M | 4,245,713 | 3.06% | 96.94% | ||||
| CYBN | CYBIN INC | $154.88M | 21,601,208 | 4.04% | 0.00% | ||||
| ENGN | ENGENE HOLDINGS INC | $184.49M | 51,105,201 | 10.37% | 37.18% | Net Buying | |||
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $58.13M | 20,984,161 | 17.16% | 82.84% | Net Buying | |||
| PMN | PROMIS NEUROSCIENCES INC | $32.64M | 51,806,497 | 0.34% | 40.99% | Net Buying | |||
| IPSC | CENTURY THERAPEUTICS INC | $47.51M | 86,389,098 | 9.44% | 45.40% | Net Selling | Net Selling | ||
| OCGN | OCUGEN INC | $301.07M | 292,304,736 | 10.20% | 10.44% | Net Selling | |||
| KAPA | KAIROS PHARMA LTD | $25.72M | 20,743,765 | 0.65% | 32.68% | Net Buying | |||
| CRDL | CARDIOL THERAPEUTICS INC | $110.70M | 82,608,992 | 6.91% | 0.00% | ||||
| TNYA | TENAYA THERAPEUTICS INC | $154.34M | 162,976,102 | 8.64% | 23.50% | Net Buying | Net Selling | ||
| ZURA | ZURA BIO LTD | $106.42M | 61,874,998 | 16.55% | 68.92% | Net Selling | |||
| ARTV | ARTIVA BIOTHERAPEUTICS INC | $65.95M | 24,425,762 | 6.38% | 64.44% | ||||
| KPTI | KARYOPHARM THERAPEUTICS INC | $40.32M | 8,671,278 | 4.22% | 95.78% | Net Selling | Net Selling | ||
| HUMA | HUMACYTE INC | $297.74M | 158,372,173 | 22.69% | 21.86% | Net Selling | |||
| AMTX | AEMETIS INC | $167.59M | 63,240,956 | 5.15% | 94.85% | Net Buying | Net Selling | ||
| EDAP | EDAP TMS SA | $50.48M | 37,392,086 | 2.06% | 0.00% | ||||
| IOBT | IO BIOTECH INC | $84.33M | 65,880,914 | 5.38% | 76.25% | Net Buying | Net Buying | ||
| TARA | PROTARA THERAPEUTICS INC | $123.08M | 38,581,863 | 17.52% | 82.48% | Net Selling | |||
| GNLX | GENELUX CORP | $128.68M | 37,734,967 | 13.98% | 5.75% | Net Selling | |||
| NKTX | NKARTA INC | $156.25M | 71,024,512 | 21.72% | 49.74% | Net Selling | Net Selling | ||
| BMEA | BIOMEA FUSION INC | $100.57M | 59,508,518 | 13.48% | 28.91% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.